Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07571993
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlinico San Matteo di PaviaRecruiting
NCT07571993Recruiting
—
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlin...
NCT07573904
Comparative Effects of Posture Correction Exercises and Papworth Technique in Asthmatic Forward Head PostureRiphah International UniversityCompletedNot Applicable
NCT07573904Completed
Not Applicable
Comparative Effects of Posture Correction Exercises and Papworth Technique in As...Riphah International Univ...
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07573267
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karate AthletesIstinye UniversityCompletedNot Applicable
NCT07573267Completed
Not Applicable
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karat...Istinye University
NCT07572214
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS Foundation TrustCompleted
NCT07572214Completed
—
Markerless Motion Capture for 3D Clinical Gait Analysis (IMAGine)Alder Hey Children's NHS...
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573046
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic DisordersHospices Civils de LyonNot Yet Recruiting
NCT07573046Not Yet Recruiting
—
Validation Study of the ExéSem Battery Designed to Differentiate the Contributio...Hospices Civils de Lyon
NCT07573189
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.University of RedlandsActive Not RecruitingNot Applicable
NCT07573189Active Not Recruiting
Not Applicable
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Mo...University of Redlands
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573696
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and ChemotherapyWen-zhao ZHONGNot Yet RecruitingPhase 2
NCT07573696Not Yet Recruiting
Phase 2
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib a...Wen-zhao ZHONG
Result Breakdown
Not yet recruiting12 (60%)
Recruiting3 (15%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 25 (25%)
Phase 42 (10%)
Phase 11 (5%)